To ensure reproducibility, we conducted additional in vivo experiments using an HMGB1-knockdown HCT116 model (Supplementary Fig. 1A, B), the results of which were consistent with the SW480 data (tumor growth inhibition p < 0.01). This evidence concerns the gene HMGB1 and neoplasm.